Non-Langerhans cell histiocytosis: Difference between revisions

From Food & Medicine Encyclopedia

CSV import
Tag: Reverted
No edit summary
Tag: Manual revert
Line 29: Line 29:
{{stub}}
{{stub}}
{{No image}}
{{No image}}
__NOINDEX__

Revision as of 13:00, 18 March 2025

Non-Langerhans cell histiocytosis is a group of rare diseases characterized by the accumulation of non-Langerhans cells, which are a type of white blood cell, in various organs and tissues. These diseases can affect both children and adults.

Classification

Non-Langerhans cell histiocytosis can be classified into several types, including Rosai-Dorfman disease, Juvenile xanthogranuloma, Erdheim-Chester disease, and Reticulohistiocytosis. Each of these diseases has unique clinical features and may affect different organs and tissues.

Symptoms

The symptoms of non-Langerhans cell histiocytosis vary depending on the specific type of disease and the organs and tissues affected. Common symptoms may include skin lesions, bone pain, and organ dysfunction.

Diagnosis

The diagnosis of non-Langerhans cell histiocytosis is typically made based on a combination of clinical findings, imaging studies, and histopathological examination of tissue samples. Immunohistochemical staining is often used to confirm the diagnosis.

Treatment

The treatment of non-Langerhans cell histiocytosis depends on the specific type of disease and the severity of symptoms. Treatment options may include surgery, radiation therapy, chemotherapy, and targeted therapies.

Prognosis

The prognosis of non-Langerhans cell histiocytosis varies widely depending on the specific type of disease and the organs and tissues affected. Some forms of the disease are self-limiting and resolve without treatment, while others may be chronic or life-threatening.

See also

References

<references />